These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33989509)

  • 21. Patient notification for bloodborne pathogen testing due to unsafe injection practices in the US health care settings, 2001-2011.
    Guh AY; Thompson ND; Schaefer MK; Patel PR; Perz JF
    Med Care; 2012 Sep; 50(9):785-91. PubMed ID: 22525612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injection Safety Practice among Health Workers in Static Immunisation Centres in an Urban Community of Nigeria.
    Musa OI
    Niger Postgrad Med J; 2005 Sep; 12(3):162-7. PubMed ID: 16160716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Syringe-type and needle gauge have no role in adverse events following DTwP immunization: a randomized multicenter trial.
    Fateh M; Emamian MH; Zahraei SM; Fotouhi A
    Pediatr Infect Dis J; 2014 Sep; 33(9):e239-46. PubMed ID: 24906043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device.
    Sutanto A; Suarnawa IM; Nelson CM; Stewart T; Soewarso TI
    Bull World Health Organ; 1999; 77(2):119-26. PubMed ID: 10083709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does knowledge about bloodborne pathogens influence the reuse of medical injection syringes among women in Pakistan?
    Janjua NZ; Mahmood B; Imran Khan M
    J Infect Public Health; 2014; 7(4):345-55. PubMed ID: 24861642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ensuring injection safety during measles immunization campaigns: more than auto-disable syringes and safety boxes.
    Hersh BS; Carr RM; Fitzner J; Goodman TS; Mayers GF; Everts H; Laurent E; Larsen GA; Bilous JB
    J Infect Dis; 2003 May; 187 Suppl 1():S299-306. PubMed ID: 12721929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cost-benefit analysis on the replacement program of ordinary syringes by auto-disposal syringes in China].
    Shi G; Xie YF; Zhang Y; Liu XY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):180-3. PubMed ID: 12816706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safer injections, fewer infections: injection safety in rural north India.
    Kermode M; Holmes W; Langkham B; Thomas MS; Gifford S
    Trop Med Int Health; 2005 May; 10(5):423-32. PubMed ID: 15860088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sterilizable syringes: excessive risk or cost-effective option?
    Battersby A; Feilden R; Nelson C
    Bull World Health Organ; 1999; 77(10):812-9. PubMed ID: 10593029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reuse of disposable insulin syringes.
    Stepanas TV; Turley H; Tuohy EA
    Med J Aust; 1982 Apr; 1(7):311-3. PubMed ID: 6806586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple reuse of disposable insulin syringes in hospital.
    Islam MS; Ali SM
    Bangladesh Med Res Counc Bull; 1990 Dec; 16(2):58-61. PubMed ID: 2096812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Injection safety in Pakistan: auto disable (AD) syringes in the curative sector.
    Altaf A
    J Pak Med Assoc; 2003 Nov; 53(11):510. PubMed ID: 14738254
    [No Abstract]   [Full Text] [Related]  

  • 33. [A cross-sectional survey on injection safety in health facilities in Wulong county, Chongqing city].
    Li Q; Ou JM; Zeng G
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):176-9. PubMed ID: 12816705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unsafe injections.
    Kane M
    Bull World Health Organ; 1998; 76(1):99-100. PubMed ID: 9615502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Injection practices in Nepal: health policymakers' perceptions.
    Gyawali S; Rathore DS; Shankar PR; Maskey M; Vikash KK
    BMC Int Health Hum Rights; 2014 Jun; 14():21. PubMed ID: 24957575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.
    Simonsen L; Kane A; Lloyd J; Zaffran M; Kane M
    Bull World Health Organ; 1999; 77(10):789-800. PubMed ID: 10593026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost of unsafe injections.
    Miller MA; Pisani E
    Bull World Health Organ; 1999; 77(10):808-11. PubMed ID: 10593028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development of an auto-retractable self-disable safety syringe with high stability].
    Zhang Y; He J; Chen O; Li H; Li X
    Zhongguo Yi Liao Qi Xie Za Zhi; 2010 May; 34(3):204-6, 208. PubMed ID: 20812647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syringe use and reuse: effects of syringe exchange programs in four cities.
    Heimer R; Khoshnood K; Bigg D; Guydish J; Junge B
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S37-44. PubMed ID: 9663622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?
    Lurie P; Jones TS; Foley J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S45-51. PubMed ID: 9663623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.